Mark Saxton, CEO of Baird Medical, highlights their microwave ablation technology, which is being used to address a significant treatment gap for benign thyroid nodules. This minimally invasive approach is an alternative to radiofrequency ablation, accommodates patients with pacemakers or other cardiac devices, and provides faster recovery. Unlike surgery, microwave ablation preserves thyroid function, eliminating the need for ongoing hormone replacement therapy

Mark explains, "It's very interesting that we're focused on thyroid tumors because they're an extremely prevalent issue. Most of those tumors are benign, and for many of those patients, active surveillance, or what we call watchful waiting, is appropriate. But a portion of those may need more than that. Their nodules are growing, they're becoming symptomatic either cosmetically or they're compressing on their throat, and that becomes extremely bothersome for them."

"A minimally invasive option, like a microwave, may be more appropriate for those patients than a surgery would be. The bottom line is there's still a huge gap between diagnosis and treatment, and that's an exciting problem for us to want to solve."

"So surgery is extremely safe and very appropriate in many patients, but there is a scar, it's a surgery, you're under general anesthetic. The other thing that surgery does is if we do a thyroidectomy, we may be destroying the thyroid's ability, obviously, then to provide the hormones, T3 and T4, that regulate some of our metabolism. So with the microwave, we just destroy the nodule. We don't impact thyroid function in that way, so patients don't need that hormone replacement. So that's another great reason to move forward with something more minimally invasive."

#BairdMedical #MicrowaveAblation #ThyroidMWA #MWA #ThyroidCare #ThyroidNodules #MinimallyInvasive #InterventionalEndocrinology #Endocrinology #PatientCare #MedicalDevices

BairdMed.com

Download the transcript here